APARIN PETR GENNADIEVICH has a total of 16 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2003. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and macromolecular chemistry and polymers are MSD WELLCOME TRUST HILLEMAN LABS PVT LTD, MSD WELLCOME TRUST HILLEMAN LABORATORIES PVT LTD and MSD WELLCOME TRUST HILLEMAN LAB PVT LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | EAPO (Eurasian Patent Organization) | 2 | |
#5 | Republic of Korea | 2 | |
#6 | Australia | 1 | |
#7 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Macromolecular chemistry and polymers | |
#4 | Environmental technology | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Climate change adaptation technologies | |
#5 | Polysaccharides | |
#6 | Macromolecular compounds compositions | |
#7 | Fermentation | |
#8 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Golovina Marina Eduardovna | 15 |
#2 | Lvov Vyacheslav Leonidovich | 14 |
#3 | Elkina Stanislava Ivanovna | 14 |
#4 | Aparin Petr Gennadievich | 14 |
#5 | Shmigol Vladimir Igorevich | 10 |
#6 | Ledov Vladimir Alekseyevich | 5 |
#7 | Markina Anna Aleksandrovna | 5 |
#8 | Shekht Maria Evgen Evna | 3 |
#9 | Elkina Stanislava Ivanovan | 1 |
#10 | Markina Anna Alexandrovna | 1 |
Publication | Filing date | Title |
---|---|---|
US2018043004A1 | Modified endotoxic bacteria lipopolysaccharide (variants), combination of modified lipopolysaccharides (variants) and, containing same, a vaccine (variants) and a pharmaceutical composition (variants) | |
KR20160029060A | Modified endotoxic bacteria lipopolysaccharide (variants), combination of modified lipopolysaccharides (variants) and, containing same, a vaccine (variants) and a pharmaceutical composition (variants) | |
US2014037687A1 | Exopolysaccharide of Shigella sonnei bacteria, method for producing same, vaccine and phamaceutical composition containing same | |
EA030920B1 | Exopolysaccharide of shigella sonnei bacteria, method for producing same, vaccine and pharmaceutical composition containing same | |
WO2004003215A1 | Method of isolating biologically active fraction containing clinically acceptable native slipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides |